Search research articles
Contact Us
Filters
Showing results (531-540 of 612) with videos related to
Page
of 62
Sort By:
Circulation. Cardiovascular Quality and Outcomes
|
July 11, 2013
Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial
John A Spertus, David J Maron, David J Cohen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
March 25, 2009
Angiographic and clinical outcomes of drug-eluting versus bare metal stent deployment in the Occluded Artery Trial
Vladimír Dzavík, Christopher E Buller, Gerard Devlin, et al.
Circulation
|
September 9, 2011
Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease
Harmony R Reynolds, Monvadi B Srichai, Sohah N Iqbal, et al.
Atherosclerosis
|
November 23, 2025
Imputation of untreated LDL-C in treated subjects with homozygous familial hypercholesterolaemia: An international collaboration
G B John Mancini, Arnold Ryomoto, Isabelle Ruel, et al.
BMJ Global Health
|
May 15, 2024
Long-term healthcare utilisation, costs and quality of life after invasive group B <i>Streptococcus</i> disease: a cohort study in five low-income and middle-income countries
Farah Seedat, Simon Procter, Ziyaad Dangor, et al.
The American Journal of Cardiology
|
May 12, 2015
Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial)
Steven M Bradley, Paul S Chan, Pamela M Hartigan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 26, 2013
Plasma protein biosignatures for detection of cardiac allograft vasculopathy
David Lin, Gabriela Cohen Freue, Zsuzsanna Hollander, et al.
Circulation. Cardiovascular Quality and Outcomes
|
July 29, 2010
Do major cardiovascular outcomes in patients with stable ischemic heart disease in the clinical outcomes utilizing revascularization and aggressive drug evaluation trial differ by healthcare system?
Bernard R Chaitman, Pamela M Hartigan, David C Booth, et al.
Journal of the American College of Cardiology
|
July 2, 2011
Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial
David J Maron, William E Boden, John A Spertus, et al.
Journal of the American Heart Association
|
June 23, 2026
Efficacy and Safety of Bempedoic Acid in Patients Aged ≥75 Years Stratified by Varying Statin Exposure: Results From Phase 3 Studies of Bempedoic Acid
G B John Mancini, A Michael Lincoff, Anne C Goldberg, et al.
Page
of 62
Search research articles
Search
Showing results (531-540 of 612) with videos related to
Sort By:
Page
of 62
Circulation. Cardiovascular Quality and Outcomes
|
July 11, 2013
Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial
John A Spertus, David J Maron, David J Cohen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
March 25, 2009
Angiographic and clinical outcomes of drug-eluting versus bare metal stent deployment in the Occluded Artery Trial
Vladimír Dzavík, Christopher E Buller, Gerard Devlin, et al.
Circulation
|
September 9, 2011
Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease
Harmony R Reynolds, Monvadi B Srichai, Sohah N Iqbal, et al.
Atherosclerosis
|
November 23, 2025
Imputation of untreated LDL-C in treated subjects with homozygous familial hypercholesterolaemia: An international collaboration
G B John Mancini, Arnold Ryomoto, Isabelle Ruel, et al.
BMJ Global Health
|
May 15, 2024
Long-term healthcare utilisation, costs and quality of life after invasive group B <i>Streptococcus</i> disease: a cohort study in five low-income and middle-income countries
Farah Seedat, Simon Procter, Ziyaad Dangor, et al.
The American Journal of Cardiology
|
May 12, 2015
Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial)
Steven M Bradley, Paul S Chan, Pamela M Hartigan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 26, 2013
Plasma protein biosignatures for detection of cardiac allograft vasculopathy
David Lin, Gabriela Cohen Freue, Zsuzsanna Hollander, et al.
Circulation. Cardiovascular Quality and Outcomes
|
July 29, 2010
Do major cardiovascular outcomes in patients with stable ischemic heart disease in the clinical outcomes utilizing revascularization and aggressive drug evaluation trial differ by healthcare system?
Bernard R Chaitman, Pamela M Hartigan, David C Booth, et al.
Journal of the American College of Cardiology
|
July 2, 2011
Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial
David J Maron, William E Boden, John A Spertus, et al.
Journal of the American Heart Association
|
June 23, 2026
Efficacy and Safety of Bempedoic Acid in Patients Aged ≥75 Years Stratified by Varying Statin Exposure: Results From Phase 3 Studies of Bempedoic Acid
G B John Mancini, A Michael Lincoff, Anne C Goldberg, et al.
Page
of 62